Skip to main content

Table 3 Anesthesia characteristics

From: Prospective investigation of intravenous patient-controlled analgesia with hydromorphone or sufentanil: impact on mood, opioid adverse effects, and recovery

 

Group S (n = 37)

Group H (n = 35)

P

Anesthetist

 Group A/Group B (n)

16/21

18/17

0.487

Anesthesia time (min)

212.95 ± 91.57

181.51 ± 63.88

0.095

Extubation time (min)

31.16 ± 27.71

39.20 ± 18.67

0.717

Duration of PACU (min)

87.11 ± 32.45

90.77 ± 27.00

0.605

Total consumption of propofol (mg)

1053.87 ± 448.71

932.57 ± 352.89

0.208

Total consumption of fentanyl (mg)

0.5 (0.4–0.5)

0.5 (0.4–0.5)

0.922

Total consumption of remifentanil (mg)

2.57 ± 1.35

2.23 ± 0.89

0.220

  1. Values are expressed as mean ± SD or median and interquartile range or number of patients